Katalin Rázsó

Complement activation in thrombotic thrombocytopenic purpura

Marienn Réti, Péter Farkas, Dorottya Csuka et al. · Journal of Thrombosis and Haemostasis · 2012 · 134 citations · Full text

Thrombopoiesis, Thrombosis, Complement System +8

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

György Sinkovits, Ágnes Szilágyi, Péter Farkas et al. · Frontiers in Immunology · 2018 · 31 citations · Full text

Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger’s Disease

Z Boda, Miklós Udvardy, Katalin Rázsó et al. · Clinical and Applied Thrombosis/Hemostasis · 2008 · 25 citations

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center

Réka Gindele, Anna Selmeczi, Zsolt Oláh et al. · Thrombosis Research · 2017 · 24 citations · Full text

Thrombosis, Venous Thrombosis, Laboratory Hematology +14

Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura

Bálint Mikes, György Sinkovits, Péter Farkas et al. · Thrombosis Research · 2014 · 20 citations

Inflammation, Thrombosis, Thrombopoiesis +12